Alcon

Alcon ups its glaucoma game again with $770M Aerie Pharma acquisition

The Aerie Pharma acquisition brings Alcon two commercialized glaucoma products, as well as a pipeline of programs in various stages of development for other eye diseases. Alcon has been an active dealmaker, turning to M&A as a way to bolster its eye products portfolio and pipeline.

By Frank Vinluan

Alphabet’s life science arm just raised $1 billion

Alphabet CFO Ruth Porat and Silver Lake Managing Director Egon Durban will be nominated to join Verily's operating board.

By Kevin Truong

Exclusive

Improving the Healthcare Financial Experience to Help Care Flow

Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.

By Stephanie Baum

Artificial Intelligence

What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations

When it comes to managing inbound phone calls, underperformance has devastating cost implications.

By Stephanie Baum

Health IT

Transforming Patient Care: The Role of AI-Powered Assistants

The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.

By IT Medical

Tips for Greater Healthcare Practice Success in 2025

Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.

By Elation Health and MedCity News